Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 04, 2015 10:17 PM ET


Company Overview of ALPHAEON Corporation

Company Overview

ALPHAEON Corporation provides beauty, wellness, and lifestyle products in the United States. It offers age defense creams for dry, normal, and combination skin; and revitalizing concentrate serums, face and eyes cleansing solutions, skin radiance smoothing creams, and deep repair soothing balms. The company offers skin care assessment solutions; credit cards that provide financing options for individuals; and PRN (Physician Recommended Nutriceuticals) products, which include omega-3 EPA and vitamin D3 soft-gels; omega-3 EPA and vitamin D3 liquids; macular vitamins; and custom-formulated omega-3 EPA, vitamin D3, and carotenoids soft-gels for dry eyes. It also helps patients to find physicians...

18191 Von Karman Avenue

Suite 500

Irvine, CA 92612

United States

Founded in 2012



Key Executives for ALPHAEON Corporation

Chief Executive Officer and Director
Age: 44
President and Chief Operating Officer
Chief Financial Officer
Age: 55
President of Alphaeon Freedom
Age: 55
President of Americas
Compensation as of Fiscal Year 2014.

ALPHAEON Corporation Key Developments

ALPHAEON Corporation Appoints Jeff Castillo as President of the Americas, and Kuntal Joshi as President of Asia Pacific

ALPHAEON Corporation announced that Jeff Castillo has joined the organization as President of the Americas, and Kuntal Joshi has joined as President of Asia Pacific. Mr. Castillo and Mr. Joshi each bring more than 25 years of experience in the medical device sector to their roles at the company. Mr. Castillo was most recently a Divisional Vice President at Abbott Medical Optics (AMO) where he focused on leading the Americas organization to double-digit growth through greater alignment and focus on customer needs and market dynamics. While at AMO, Jeff was responsible for deploying a customer focused strategy concentrating on strengthening AMO's value proposition through the creation of new services, launching value added products, and maximizing the portfolio. Prior to AMO, Mr. Castillo spent 22 years at Johnson & Johnson, where he held a variety of senior commercial positions based in the U.S. and Latin America. Prior to joining ALPHAEON, Mr. Joshi spent the last 12 years in the Asia Pacific Region.

FDA Accepts Investigational New Drug Application for ALPHAEON's Neurotoxin EVOSYAL

ALPHAEON(R) Corporation, subsidiary of Strathspey Crown Holdings LLC, announced that the U.S. Food and Drug Administration (FDA) accepted the Investigational New Drug (IND) application to conduct clinical studies for EVOSYAL(TM), an advanced Botulinum toxin Type A neurotoxin that was acquired by ALPHAEON last October, as part of the acquisition of Evolus Inc. According to the ASPS(R), Botulinum toxin Type A was injected for cosmetic purposes more than 6 million times last year, accounting for over 2 billion dollars of consumer spend annually, which was a 3% increase from the previous year. ALPHAEON expects the initial clinical trial to be fully enrolled by the end of 2014.

ALPHAEON Corporation Announces Executive Changes

ALPHAEON Corporation named a team of leaders in healthcare and business to its board of directors. The company's directors include the following industry leaders: Robert E. Grant, chief executive officer of the company, presently serves as chairman and managing partner of Strathspey Crown Holdings, LLC, company's parent company. For more than 20 years, he has played a pivotal role in successful technology and business development in the pharmaceutical, medical device and healthcare markets. Most recently, he was CEO and president of Bausch + Lomb Surgical and also previously served as president of Allergan Medical, a division of Allergan Inc. Robert Hayman, founder & former chairman and chief executive officer of Discus Dental Inc. Hans Keirstead, Ph.D., is an internationally known stem cell expert that has worked on stem cell-based therapies for late stage cancers, motor neuron diseases, spinal cord injury and retinal diseases. He has served as Founder, President and CEO of Ability Biomedical, where he led the development of an immunotherapy, which he sold to Bristol Myers Squibb, and later California Stem Cell Inc., which was acquired by NeoStem in May 2014. He currently serves as president of NeoStem Oncology. He founded the Sue and Bill Gross Stem Cell Research Center and served as Full Professor of Anatomy and Neurobiology. Richard L. Lindstrom, M.D., is founder and attending surgeon of Minnesota Eye Consultants and Adjunct Clinical Professor Emeritus at the University of Minnesota's Department of Ophthalmology; Associate Director of the Minnesota Lions Eye Bank and Visiting Professor at the University of California Irvine's Gavin Herbert Eye Institute. Dr. Lindstrom currently serves on the Board of Directors of AcuFocus Inc., TLC Vision, TearLab, Refractec, Wavetec, Encore, RevitalVision, and the University of Minnesota Foundation. Vikram Malik is a managing partner in the growth equity firm Strathspey Crown Holdings LLC, company's parent company. During a 26-year career on Wall Street, Mr. Malik recently served as vice chairman of Investment Banking and Global Head of Medical Technology at Deutsche Bank. Patrick Maxwell, M.D., is a clinical professor of plastic surgery at California's Loma Linda University and Vanderbilt University in Nashville. Dr. Maxwell, who also maintains a private practice, Maxwell Aesthetics, has published more than 140 scientific articles, holds 16 U.S. patents for medical devices and co-founded Precision Light recently acquired by Allergan, and is a founder, principle in GID (an adipose/adipose-derived stem cell company). He also designed the Natrelle(R) silicone gel collection of breast implants for Allergan Inc., and founded and chairs the Allergan Academy. Valerie Taupin is founder, chief executive officer and chairman of TEOXANE Laboratories. Joseph Whitters, C.P.A. is a seasoned director and corporate advisor. He currently serves on the board of directors of publicly traded PRGX Global Inc. and InfuSystems Holdings Inc. Chris Cox, a former 17-year member of the U.S. House of Representatives, is a partner in the international law firm Bingham McCutchen LLP and president of Bingham Consulting LLC. He advises global companies on strategic issues, corporate governance, securities regulation and general business. Mr. Cox served as the 28(th) chairman of the Securities and Exchange Commission and chairman of the Homeland Security Committee in the house. Previously, he served as White House counsel to President Ronald Reagan and as corporate partner at Latham & Watkins.

Similar Private Companies By Industry

Company Name Region
Western Utilities Supply Co., Inc. United States
Ken Young Food Distributors, Inc. United States
BWP Distributors, Inc. United States
Mascioni Hospitality Inc. United States
Magbee Contractors Supply United States

Recent Private Companies Transactions

Private Placement
January 14, 2015
September 8, 2014
Clarion Medical Technologies Inc.
July 28, 2014
LifeGuard Health, LLC

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALPHAEON Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at